XORTX Therapeutics Inc (XRTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.00M
Last updated: Nov 17, 2026 at 4:15 PM ET
XORTX Therapeutics Inc (XRTX) Stock Chart
XORTX Therapeutics (XRTX) has a latest price of $1.06 on Nov 17, 2026, 70.6% below its 52-week high of $3.60. Its price fell 61.9% over the past 12 months. The month-end price fell 99.2% over the 5 years through Oct 2026, a compound annual decline of 62.0%.
Price Chart
From Nov 2019 to Oct 2026, its highest month-end close was $215.35 in Sep 2021 and its lowest $1.00 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart XRTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XRTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 47.0%, and over 6 months it fell 54.3%. The month-end price fell 92.7% over the 3 years through Oct 2026, a compound annual decline of 58.1%.
| Period | Change |
|---|---|
| 1 month | +5.0% |
| 3 months | -47.0% |
| 6 months | -54.3% |
| 12 months | -61.9% |
| 12 months, with dividends | -61.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -92.7% | -58.1% |
| 5 years | -99.2% | -62.0% |
Price by Year
Its best calendar year was 2021, when the price rose 50.6%, and its weakest was 2023, when it fell 68.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.00 | -64.4% |
| 2025 | $2.81 | -50.2% |
| 2024 | $5.65 | -51.1% |
| 2023 | $11.55 | -68.2% |
| 2022 | $36.36 | -60.6% |
| 2021 | $92.26 | +50.6% |
| 2020 | $61.27 | -11.2% |
Trading Range
The price is 25.3% below its 50-day average of $1.42 and 47.5% below its 200-day average of $2.02.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.06 | |
| 52-week high | $3.60 | -70.6% |
| 52-week low | $0.81 | +30.1% |
| 50-day average | $1.42 | -25.3% |
| 200-day average | $2.02 | -47.5% |
Price Risk
Over 3 years, its largest fall from a peak was 97.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.79 |
| Largest fall, 1 year | -73.9% |
| Largest fall, 3 years | -97.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About XRTX
What is XRTX's 1-year price change?
XORTX Therapeutics's price fell 61.9% over the past 12 months. With dividends included, the 12-month total return was -61.9%.
What is XRTX's 5-year price change?
XORTX Therapeutics's month-end price fell 99.2% over the 5 years through Oct 2026, a compound annual decline of 62.0%. These figures leave out dividends.
What is XRTX's 52-week high and low?
XORTX Therapeutics's 52-week high is $3.60 and its 52-week low is $0.81. Its latest price of $1.06 on Nov 17, 2026 is 70.6% below the high.
What is XRTX's beta?
XORTX Therapeutics's 1-year beta against the S&P 500 is 0.79, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 73.9%.
Is the XRTX chart free?
Yes. Advanced Charting for XRTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
XRTX pages: Overview, Charting, Competitors